
The Neuroscience of Depression
- 1st Edition - March 22, 2021
- Imprint: Academic Press
- Editors: Colin R. Martin, Lan-Anh Hunter, Vinood Patel, Victor R Preedy, Rajkumar Rajendram
- Language: English
- Paperback ISBN:9 7 8 - 0 - 1 2 - 8 1 8 0 0 9 - 9
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 1 8 0 1 0 - 5
The Neuroscience of Depression: Genetics, Cell Biology, Neurology, Behaviour and Diet is a comprehensive reference to the aspects, features and effects of depression. This book p… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteThe Neuroscience of Depression: Features, Diagnosis and Treatment
- Covers a pharmacological and behavioral treatment options
- Features sections on diagnosis and biomarkers of depression
- Discusses depression in children, teens and adults
- Contains information on comorbidity of physical and mental conditions
- Includes more than 250 illustrations and tables
The Neuroscience of Depression: Genetics, Cell Biology, Neurology, Behaviour and Diet
- Features a section on neurological and imaging, including SPECT Neuroimaging
- Analyzes how diet and nutrition effect depression
- Examines the molecular and cellular effects of depression
- Covers genetics of depression
- Includes more than 250 illustrations and tables
- Cover image
- Title page
- Table of Contents
- Copyright for Volume 1
- Contributors for Volume 1
- Foreword for Volume 1
- Preface for Volume 1
- Copyright for Volume 2
- Contributors for Volume 2
- Foreword for Volume 2
- Preface for Volume 2
- Volume 1
- Part I: Depression: Introductory chapters
- Chapter 1: Clinical staging in depression
- Abstract
- Introduction
- Clinical staging in depression
- Clinical staging and progression in depression
- Clinical staging and treatment-resistant depression
- Conclusion
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 2: Neurodevelopmental theory of depression
- Abstract
- Introduction
- Early childhood experience and personality traits
- The affective and rational system—The basis for personality formation
- Emotional immunity or immune emotionality?—The key to understanding depression
- Mother’s fear as well as grandmother’s fear as a source of depression
- Early childhood trauma
- Glucocorticoid cascade hypothesis—Epigenetics again?
- Personality of the 21st century
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 3: Depression after pregnancy
- Abstract
- Introduction
- Epidemiology
- Consequences of postpartum depression
- Neurobiological basis of PPD
- Management of PPD
- Prevention of PPD
- Summary points
- Mini-dictionary of terms
- Chapter 4: Modeling maternal depression during pregnancy: Rodent models of major depressive disorder with peripartum onset
- Abstract
- Introduction
- Characteristics of animal models of maternal depression
- Face validity of animal models of maternal depression; symptoms and other physiological markers that resemble those found in humans and are used to verify the model
- Construct validity of maternal models of depression: The mode of induction of depression
- Predictive validity of rodent models of maternal depression: Response to antidepressants
- Summary of studies addressing the impact of maternal depression on preadolescent and adolescent offspring
- Future animal models of maternal depression
- Conclusions
- Key facts of maternal depression during pregnancy
- Summary points
- Mini-dictionary of terms
- Chapter 5: Depression in mothers and mental health in their children: Impact, risk factors, and interventions
- Abstract
- List of abbreviations
- Introduction
- Effects of maternal depression on mental health of children
- Risk factors
- Interventions to reduce the impact of maternal depression on children
- Conclusion
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 6: The neuroscience of depression: Mechanisms and treatments
- Abstract
- Introduction
- Overview of depression in students
- Screening depression
- Treatment and management
- Risk behaviors in students
- Conclusion
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 7: Depression in disasters and traumatic events
- Abstract
- Introduction
- Clinical diagnosis and standardized assessment instruments for depression
- Depression after natural disasters and traumatic events
- Consequences of depression after natural disasters and traumatic events
- Causes and risk factors of depression
- Biological factors and depression after disaster events
- Implications and suggestions
- Key facts of depression
- Summary points
- Mini-dictionary of terms
- Chapter 8: Depression and associated Alzheimer’s disease
- Abstract
- Introduction
- Coexistence of depression and Alzheimer’s disease
- Dysfunction of the hypothalamic-pituitary-adrenal axis
- Chronic inflammation in depression and Alzheimer's disease
- Alteration in monoamines level
- TGF signaling
- Long-term potentiation alteration
- Oxidative stress
- Therapeutic management of AD
- Conclusion
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 9: Comorbidities of depression and Parkinson’s disease
- Abstract
- Introduction
- Depression in Parkinson’s disease
- Pathophysiology of stress leading to depression
- Biochemical scheme of depression
- Coexistence of Parkinson’ disease and depression
- 5HT receptors and Parkinson’s disease
- Role of serotonin in depression associated with Parkinson’s disease
- Clinically available serotonergic drugs
- Noradrenergic systems in the central nervous system
- The locus coeruleus (LC)
- Role of NA in PD symptoms
- Indication for the interaction between DA and NA in PD
- The locus coeruleus noradrenergic system in PD
- Conclusion
- Key facts of comorbidities of depression and Parkinson’s disease
- Mini-dictionary of terms
- Summary points
- Chapter 10: Understanding the relationship between depression and alcohol among students
- Abstract
- Introduction
- Examining the association between alcohol and depression in students
- Influence of mental health on alcohol and depression
- Influence of sociodemographic variables on alcohol and depression
- Influence of drinking motives on alcohol and depression
- Other drinking motives and its relationship with depressive symptoms
- Key facts of alcohol and depression among students
- Summary points
- Mini-dictionary of terms
- Chapter 11: Depression in obesity
- Abstract
- Introduction
- Obesity
- Depression in obesity
- Cross-sectional or prospective studies
- Systematic reviews
- Conclusion
- Key facts of obese people in bariatric surgeries
- Summary points
- Examples of mini-dictionary of terms
- Chapter 12: Heart rate variability and depression
- Abstract
- Introduction
- HRV measurement
- Association of depression and HRV
- HRV in depression and cardiovascular comorbidity
- The effect of antidepressants on HRV
- HRV and response to depression treatment
- Treating depression by intervention on the autonomic system
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 13: Neuroinflammation and depression
- Abstract
- General aspects of neuroinflammation
- Evidence about neuroinflammation in depression
- Mechanisms whereby neuroinflammation leads to alterations in brain structure/function in depression: Lessons from animal models
- Peripheral inflammation and brain function in depression
- Possible origins of increased neuroinflammation in depression
- Neuroinflammation-related mediators as biomarkers of depression
- Neuroinflammation as commonplace for stress and depression
- Anti-inflammatory effects of antidepressants
- Antiinflammatory agents in depression
- Clinical implications and future research
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 14: Interlinking antidepressants and the immune system
- Abstract
- Introduction
- The immune system in the depression
- Influence of antidepressants on the immune system
- Selective serotonin reuptake inhibitors
- Conclusions
- Key facts
- Summary points
- Mini-dictionary of terms
- Part II: Biomarkers and diagnosis
- Chapter 15: Assessment scoring tools of depression
- Abstract
- Introduction
- Comments
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 16: The Beck depression inventory: Uses and applications
- Abstract
- Introduction
- Versions
- Content description
- Target population
- Application
- Guidelines
- Interpretation of scores
- Validity
- Factors that affect the score
- Limitations
- Comments
- How to obtain
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 17: Hamilton depression rating scale: Uses and applications
- Abstract
- Introduction
- Administration and uses
- Scoring and interpretation
- Indication for the use of the HDRS
- Validity and reliability
- Limitations
- Key facts of the Hamilton depression rating scale
- Summary points
- Mini-dictionary of terms
- Chapter 18: The patient health questionnaire (PHQ)
- Abstract
- Introduction
- Content and scoring
- Abbreviated versions
- Psychometric characteristics
- Screening and case-finding properties
- Comparison with other psychometric instruments
- Special populations
- Conclusions
- Key facts of PHQ
- Summary points
- Mini-dictionary of terms
- Chapter 19: Screening for antenatal depression (AND) using self-report questionnaires: Conceptual issues and measurement limitations
- Abstract
- Introduction
- The etiological paradox of PDD
- Screening for AND: Measurement issues
- Measuring continuity of PDD across the reproductive spectrum
- Psychometric characteristics
- Screening measure item content and overlaps
- Screening for AND: Which measures perform best?
- The nine-item Patient Health Questionnaire (PHQ-9)
- The “Whooley questions”
- Beyond guidelines: Other questionnaires for the detection of depression
- Conclusion
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 20: Edinburgh postnatal depression scale: Description and applications
- Abstract
- Introduction
- Edinburgh postnatal depression scale
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 21: The death depression scale: Description and applications
- Abstract
- The death depression scale (DDS)
- The DDS items
- The death depression scale-revised (DDS-R)
- Discussion
- Key facts of the death depression scale (DDS)
- Mini-dictionary of terms
- Chapter 22: The Depression Anxiety Stress Scale: Features and applications
- Abstract
- Acknowledgments
- Introduction
- Psychometric properties
- Validity of extending the DASS to additional populations and administration formats
- Applications
- Summary
- Conclusion
- Key facts of translations/adaptations of tests or measures
- Summary points
- Mini-dictionary of terms
- Chapter 23: Arabic version of the two-question quick inventory of depression (QID-2-AR): Description and applications
- Abstract
- Disclosure of potential conflicts of interest
- Introduction
- Human plague
- Negative impacts of depression
- Depression undetected and undiagnosed
- Burden time and effort to screening of depression
- Difficulty of detecting depression
- Depressed mood and anhedonia
- Effective screening
- Multiple cultures recommended of QID-2
- QID-2 test alternative of scales
- Utility of QID-2
- Description of QID-2
- Description of diagnostic cutoff value for the QID-2
- Recommendations the threshold score of QID-2
- Applications of QID-2 and recommendations
- Discussion
- Implications of QID-2 in care for good clinical practice
- QID-2, depression, clinicians, patients, busy clinics, and wartime
- Conclusion
- Key facts of depression
- Key facts of QID-2
- Summary points
- Mini-dictionary of terms
- Chapter 24: Depression and biomarkers of cardiovascular disease
- Abstract
- Depression and cardiovascular disease
- What is a biomarker?
- Associations between depression and biomarkers of cardiovascular disease
- Functional biomarkers
- Circulating biomarkers
- Structural biomarkers
- Psychosocial factors impacting the depression-biomarkers relationship
- Limitations of measuring biomarkers
- Future directions
- Summary and conclusions
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 25: Thioredoxin as an antioxidant protein as a marker in depression
- Abstract
- Introduction
- Role of oxidative stress in depressive disorder
- Key facts of thioredoxin
- Summary points
- Mini-dictionary of terms
- Chapter 26: Methods of neuroimaging in depression: Applications to resting-state functional connectivity
- Abstract
- Acknowledgments
- Disclosure of conflicts of interest
- Introduction
- Childhood and adolescence
- Adulthood
- Conclusions
- Summary points
- Chapter 27: Neural markers of depression in MRI
- Abstract
- Introduction
- Introduction and concept of MRI and FMRI
- Hypothetic model in depression
- Structural neural marker in MDD: GM aspect
- Structural neural marker in MDD: WM aspect
- Functional neural marker in MDD: Task FMRI aspect
- Functional neural marker in MDD: Rs-FMRI aspect
- Key facts of neural MRI markers in MDD
- Summary points
- Mini-dictionary of terms
- Part III: Pharmacological treatments for depression
- Chapter 28: Angiotensin receptor 1 blockade as an antidepression strategy
- Abstract
- Introduction
- Renin-angiotensin-aldosterone system in the brain
- Experimental data and clinical studies
- Brain-derived neurotrophic factor
- Diabetes and comorbid depression
- Key facts of role of RAAS in mood disorders
- Summary points
- Mini-dictionary of terms
- Chapter 29: The link between cannabinoids and depression
- Abstract
- Introduction
- Distribution of cannabinoid receptors in the central nervous system
- Cannabinoid receptor signaling pathways
- Cannabinoids and depression disorder: Clinical evidence
- Cannabinoids and depression disorder: Preclinical evidence
- Possible mechanisms in the effects of cannabinoids on depression
- Conclusion
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 30: Agomelatine: Profile and applications to depression
- Abstract
- Introduction
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics, metabolism, and drug interactions
- Clinical efficacy in depressive episodes
- Bipolar depression
- Depression in medical comorbidities
- Side effect profile
- Serious adverse events
- Safety on overdose
- Conclusions
- Key facts of agomelatine
- Mini-dictionary of terms
- Chapter 31: Bumetanide and use in depressive states
- Abstract
- Summary points
- Key facts
- Mini-dictionary of terms
- Chloride homeostasis and depression
- Perspective in the use of bumetanide as a therapeutic agent
- Chapter 32: Linking citalopram, serotonin reuptake inhibitors, and depressed pregnant women
- Abstract
- Introduction
- Development of serotonergic systems
- Role of 5-HT in neural development and behavior
- Pharmacokinetics of SSRIs
- Prenatal exposure to SSRIs in humans
- Effects of prenatal SSRI administration in normal pregnant rodents
- SSRI administration to stressed mothers: Effect on offspring behavior
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 33: Citalopram and its use in sleep-deprivation-induced depression
- Abstract
- Acknowledgments
- Introduction
- Prevalence of SD
- Sleep loss as a risk factor for depression
- Sleep deprivation-induced molecular deficits—Effects of antidepressants
- Synaptic plasticity and SD
- Effects of CTM on SD-induced depression
- Concluding remarks
- Key facts about sleep deprivation
- Summary points
- Mini-dictionary of terms
- Chapter 34: Monoaminergic system and antidepressants
- Abstract
- Introduction
- Serotonin
- Noradrenaline and adrenaline
- Dopamine and antidepressants
- Other monoamines (histamine, melatonin, and tryptamine hallucinogens)
- Conclusion
- Key facts of antidepressants
- Summary points
- Mini-dictionary of terms
- Chapter 35: Duloxetine usage in depression
- Abstract
- Acknowledgment
- Introduction
- Pharmacokinetic profile
- Duloxetine for depression and its associated symptoms
- Effects of duloxetine on depression in gynecology and obstetrics
- Effects of duloxetine on treatment–resistant depression
- Effects of duloxetine on depression with comorbidities
- Side effects
- Key facts of duloxetine
- Summary points
- Mini-dictionary of terms
- Chapter 36: Escitalopram and blonanserin as antidepressant agents linking in neurotrophic mechanisms
- Abstract
- Introduction: Modern molecular theory of depression
- BDNF as a leading player in depression
- Role of BDNF in corticosterone hormone stress-induced depression model
- BDNF signaling activation and underlying mechanisms
- Trophic mechanism in chronic, recurrent depression—Early life adversity
- Trophic mechanism in chronic, recurrent depression—Adolescent
- Possible antidepressant activity as adjunctive agent
- Potential mechanism of antidepressant action induced by blonanserin
- Possible BDNF/GABA activation by blonanserin through D3 receptors
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 37: (2R,6R)-Hydroxynorketamine as a novel antidepressant and its role in the antidepressant actions of (R,S)-ketamine
- Abstract
- Introduction
- Metabolism of (R,S)-ketamine
- Antidepressant effects of (2R,6R)-HNK
- Mechanisms underlying the antidepressant effects of (2R,6R)-HNK
- Role of (2R,6R)-HNK in the antidepressant effects of (R)-ketamine
- Conclusion
- Key facts of major depressive disorder
- Summary points
- Mini-directory of terms
- Chapter 38: Linking 5-hydroxytryptamine to antidepressant actions of (R)-ketamine and social stress model
- Abstract
- Introduction
- (R,S)-Ketamine
- Linking 5-HT and the antidepressant actions of (R)-ketamine in a chronic social stress model
- Conclusion
- Key facts
- Summary points
- Chapter 39: Mirtazapine: Multitarget strategies for treating substance use disorder and depression
- Abstract
- Introduction
- Substance use disorder (SUD)
- MDD-SUD comorbidity
- Neurobiological mechanisms of DD (MDD-SUD)
- Mirtazapine
- Mirtazapine-SUD
- Preclinical studies
- Clinical trials
- Preclinical studies in models of polydrug
- Selective agent therapies
- Multitarget therapy
- Conclusion and future perspectives
- Key facts
- Summary points
- Mini-dictionary of terms
- Part IV: Counselling, psychotherapy and behavioural treatments for depression
- Chapter 40: Mindfulness-based cognitive therapy and depression
- Abstract
- Overview
- Mindfulness-based interventions and depression
- MBCT for prevention of depressive relapse
- MBCT in the treatment of current depression
- MBCT for TRD
- Mechanisms of change in MBCT
- MBCT for depression associated with chronic illness
- Summary and future directions in the use of MBCT
- Key facts of mindfulness-based cognitive therapy and depression
- Summary points
- Mini-dictionary of terms
- Chapter 41: Online programs for depression
- Abstract
- Introduction
- The structure and function of online programs
- Self-guided vs clinician-supported programs
- Evidence for the effectiveness of online programs
- Examples of effective programs
- Opportunities and challenges in delivering online programs
- The future of online programs
- Conclusion
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 42: Clay art therapy on emotion regulation: Research, theoretical underpinnings, and treatment mechanisms
- Abstract
- Introduction
- Section one: Emotion regulation: Research and theories relating visual art to neuroscience
- Section two: Therapeutic functions of clay on emotion regulation
- Section three: Treatment mechanisms of clay art therapy for emotion regulation
- Concluding comments
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 43: Solution-focused counseling and its use in postpartum depression
- Abstract
- List of abbreviations
- Introduction
- Solution-focused brief therapy and counseling
- Solution-focused brief therapy principles
- Solution-focused brief therapy methods and techniques
- The structure of solution-focused brief therapy and counseling
- Solution-focused brief therapy as a practical skill in preventing postpartum blues and depression
- Mini-dictionary of terms
- Key facts of solution-focused brief therapy
- Summary points
- Chapter 44: Transcranial direct current stimulation (tDCS) combined with cognitive emotional training (CET) as a novel treatment for depression
- Abstract
- Introduction
- Transcranial direct current stimulation (tDCS)
- Clinical effects of tDCS in MDD
- Rationale for combining tDCS and CET in MDD
- Cognitive emotional training (CET)
- Clinical effects of CET
- Preliminary evidence for clinical effects of tDCS combined with CET
- Neurophysiological effects of tDCS combined with CET
- Conclusions and future research
- Key facts of tDCS and CET
- Summary points
- Part V: Other aspects of treatment: Specific groups, monitoring and novel regimens
- Chapter 45: Putative effects of cannabidiol in depression and synaptic plasticity
- Abstract
- Acknowledgments
- Disclosures
- Introduction
- Cannabidiol pharmacology and therapeutic potential
- The effects of CBD in animal models of depression
- CBD effects on depressed patients
- Final considerations
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 46: Transcutaneous auricular vagus nerve stimulation in the treatment of depression
- Abstract
- Introduction
- Clinical trials on taVNS treatment of depression
- Potential side effects of taVNS
- Potential mechanisms underlying taVNS treatment of depression
- Challenges and future directions
- Key facts of taVNS
- Summary points
- Mini-dictionary of terms
- Chapter 47: Exercise for depression as a primary and comorbid with obesity disorder: A narrative
- Abstract
- Introduction
- Clinical attributes of trials reviewed by meta-analyses
- Meta-analysis for AE in adult MDD patients in mental health services
- Pragmatic evidence for exercise and depression
- Ideographic vs nomothetic exercise
- Pragmatic trial ideographic vs nomothetic exercise for depression
- Individual clinical significant analysis
- Exercise for depression as a comorbid with obesity disorder
- Additional exercise trials for depression as a comorbid with obesity disorder
- Collective evidence
- Key facts of the safety of exercise for depressed patients
- Summary points
- Examples of mini-dictionary of terms
- Chapter 48: Acupressure and depression: A scientific narrative
- Abstract
- Introduction
- Basic concepts of acupressure
- Application of acupressure
- Research evidences for the effect of acupressure on depression
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 49: Potential beneficial effects of Bifidobacterium breve A1 on cognitive impairment and psychiatric disorders
- Abstract
- Microbiota-gut-brain axis
- MGB axis in Alzheimer’s disease
- MGB axis in schizophrenia
- Bifidobacterium breve A1 as probiotics
- Administration of B. breve A1 to subjects with mild cognitive impairment
- Effect of B. breve A1 on anxiety and depressive symptoms in schizophrenia
- No significant change in the gut microbiota was observed, but B. breve A1 may have affected gut epithelial barrier function
- Dietary habits and baseline gut microbiota could influence the effect of B. breve A1 on anxiety and depressive symptoms
- Conclusions and perspectives
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 50: Coenzyme Q10 and depression
- Abstract
- A brief introduction to depression treatment regimens
- CoQ10 and its pharmacological application
- Correlation of CoQ10 with depression
- Conclusion
- Key facts of mice behavioral tests
- Key facts of human depression studies
- Key facts of oxidative stress and antioxidants
- Summary points
- Mini-dictionary of terms
- Chapter 51: Gene expression in major depressive disorder: Peripheral tissue and brain-based studies
- Abstract
- Introduction
- Gene expression and its measurement
- Candidate gene vs whole-genome approaches
- Confounding, expression, and causality
- Differential expression (DE) studies
- Gene expression as mediators of genetic risk
- Tissue specificity and the use of surrogate markers
- Peripheral tissue studies in MDD
- Brain-based studies in MDD
- Single-cell sequencing
- Emerging themes
- Integration with genetic risk
- Future directions
- Triangulation and strengthening of causal claims
- Summary
- Summary points
- Mini-dictionary of terms
- Chapter 52: Electroconvulsive therapy for depression: Effectiveness, cognitive side-effects, and mechanisms of action
- Abstract
- Summary of ECT effectiveness research
- Cognitive effects
- ECT’s mechanism of action models
- Future directions: Testing an integrated model
- Key facts for electroconvulsive therapy
- Summary points
- Mini-dictionary of terms
- Chapter 53: Prenatal depression and offspring DNA methylation
- Abstract
- Prenatal maternal depression
- Developmental origins of health and disease (DOHaD)
- Epigenetics mechanisms
- Epigenetics studies of fetal exposure to maternal depression
- Recommendations for future research
- Conclusion
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 54: Treating depression with theta burst stimulation (TBS)
- Abstract
- Introduction
- Role of transcranial magnetic stimulation in depression
- Mechanism of action of theta-burst stimulation and its types
- Key facts
- Summary
- Mini-dictionary terms
- Volume 2
- Part I: Genetic aspects of depression
- Chapter 1: Epigenetics in depression
- Abstract
- Introduction
- DNA methylation
- Early-life events, DNA methylation, and depression
- Different gene methylation profiles in depression models
- Histone modifications
- Histone acetylation and depression
- Histone methylation and depression
- HDAC inhibitors as antidepressants
- Histone modification associated with gestational stress and gender differences
- miRNA mechanisms of action
- miRNAs and neuroplasticity in depression
- miRNAs and animal models of depression
- miRNAs and postmortem brain
- miRNAs as a peripheral markers of depression
- Conclusion
- Key facts of epigenetics
- Summary points
- Mini-dictionary of terms
- Chapter 2: Genes, depression, and nuclear DNA
- Abstract
- Introduction
- Heritability of depression
- Heterogeneity of depression
- The multifactorial background of depression
- The candidate gene approach in depression
- Genome-wide analytical studies (GWAS) in depression
- Phenotyping of depression in genetic studies
- Genetic architecture of depression
- Implications of genetic studies of depression for clinical practice
- Conclusion
- Summary points
- Key facts
- Mini-dictionary of terms
- Chapter 3: Gene expression in depression: Molecular aspects of postpartum depression
- Abstract
- Introduction
- What is known about PPD etiology?
- Molecular biology approaches for the study of PPD: The experimental models
- Genetic factors for PPD: The female reproductive hormones
- Genetic factors for PPD: The neuropeptides and mood modulators
- Genetic factors for PPD: The HPA axis
- Genetic factors for PPD: The immunoinflammatory response
- Genetic factors for PPD: The microarray studies
- Genetic factors for PPD: The epigenetics
- The importance of the molecular markers for the PPD diagnosis
- Key facts of PPD
- Summary points
- Mini-dictionary of terms
- Chapter 4: Genetics and epigenetics of the SLC6A4 gene in depression
- Abstract
- List of abbreviations
- Introduction
- The role of the serotoninergic system in neurodevelopment depression
- Genetic variations in the serotonin transporter gene and the risk for depression
- Stress events and epigenetic changes
- Perspectives on the SLC6A4 contribution for depression etiology
- Key facts of SLC6A4
- Summary points
- Mini-dictionary of terms
- Chapter 5: Molecular basis of tryptophan metabolism disorders associated with depression
- Abstract
- Introduction
- Genetic background of disorders of tryptophan metabolism in depression
- Disorders of tryptophan metabolism and antidepressant therapy
- Compensatory (anti)inflammatory reflex system in depression
- Disorders of tryptophan metabolism in the development of postpartum depression
- Conclusion
- Key facts
- Summary points
- Mini-dictionary terms
- Chapter 6: Metalloproteinases genes and their relationship with depression
- Abstract
- Introduction
- Overview
- Structure, history, classification, and regulation
- Pathophysiological role
- Pathophysiology of depression
- Pharmacotherapy
- Conclusion
- Key facts of matrix metalloproteinases in depression
- Summary points
- Mini-dictionary of terms
- Chapter 7: Linking gene regions jointly with environment and depression
- Abstract
- Introduction
- Candidate gene methods in GxE research
- Gene-region analyses: A primer
- Selecting gene regions
- Gene-region analyses in depression research
- Challenges and future directions
- Key facts of gene region x environment analysis in depression
- Summary points
- Mini-dictionary of terms
- Part II: Molecular and cellular effects of depression
- Chapter 8: Linking depression, mRNA translation, and serotonin
- Abstract
- Introduction
- mRNA translation: A central process in regulating gene expression
- Dysregulated inflammation in MDD
- Conclusions
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 9: Changes in cortical gene expression in major depressive disorders: More evidence implicating inflammatory-related pathways in disease etiology
- Abstract
- Cortical dysfunction in major depressive disorders
- Gene x environment interactions in major depressive disorders
- Cortical gene expression in major depressive disorders
- Regional changes in cortical gene expression in major depressive disorders
- Changes in gene expression in the frontopolar cortex
- Changes in gene expression in the orbitofrontal cortex
- Changes in gene expression in the dorsolateral prefrontal cortex
- Changes in gene expression in the ventrolateral prefrontal cortex
- Changes in gene expression in the cingulate cortex
- Changes in gene expression in the premotor and primary motor cortices
- Changes in gene expression in the temporal cortex
- Changes in gene expression in the pre-visual cortex
- Summary of changed cortical gene expression in major depressive disorders
- From transcriptomics to a biology of major depressive disorders
- Conclusions
- Key facts
- Summary points
- Chapter 10: FKBP5 gene expression as a biomarker for treatment outcome in depression
- Abstract
- Depression—A stress-related mental disorder
- Role of FKBP5 in stress response regulation and mood disorders
- FKBP5 gene expression and antidepressant treatment outcome
- FKBP5 as a promising antidepressant drug target
- Key facts and summary points
- Mini-dictionary of terms
- Chapter 11: Neuroimaging a cytokine storm by transducing IL-1α to hippocampal cornu ammonis: COVID-19 SARS-CoV-2
- Abstract
- Acknowledgments
- Introduction
- Main text
- Nanobiotechnology model: The device and the circuits
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 12: Linking interleukin-6 and depression
- Abstract
- Introduction
- Interlinking interleukin-6 and depression
- Historical background
- Review of IL-6 function
- Preclinical studies
- Clinical studies of immune system disorders or immunoactive treatments
- Clinical studies of patients with MDD or other depressive disorders
- Clinical treatments involving blockade of IL-6 activity
- Mechanisms of interaction of IL-6 and depression
- Limitations
- Future areas of research
- Conclusion
- Key facts
- Summary points
- Chapter 13: The role of inflammatory signaling in comorbid depression and epilepsy
- Abstract
- Introduction
- Inflammation in depression and epilepsy
- The role of inflammation in epilepsy and depression comorbidity
- Conclusions
- Key facts of inflammation in comorbid depression and epilepsy
- Summary points
- Mini-dictionary of terms
- Chapter 14: Brain inflammasomes in depression
- Abstract
- Introduction
- Inflammasomes, structure-function relationship and role in brain diseases
- Major depressive disorders
- Linking depressive disorders to neuroinflammation
- Inflammasomes are key players in MDD
- Conclusion
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 15: Inflammatory factors and depression in substance use disorder
- Abstract
- Introduction
- Substance use disorder
- Comorbidity: Substance use disorder and depression
- Inflammation in substance use disorder and depression
- Conclusions and identification of inflammatory biomarkers
- Key facts of substance use disorder
- Key facts of inflammation
- Summary points
- Mini-dictionary of terms
- Chapter 16: Linking Huntington disease, brain-derived neurotrophic factor, and depressive-like behaviors
- Abstract
- Huntington’s disease
- Brain-derived neurotrophic factor
- The role of brain-derived neurotrophic factor in depression
- Alterations of brain-derived neurotrophic factor signaling in HD
- Depression in HD: A putative role for brain-derived neurotrophic factor
- Conclusions
- Key facts on Huntington’s disease
- Summary points
- Mini-dictionary of terms
- Chapter 17: Depression and the NMDA receptor/NO/cGMP pathway
- Abstract
- Introduction
- The glutamatergic system and the l-arginine/NO/cGMP pathway
- NMDA receptor/NO/cGMP pathway as therapeutic target for depression
- NMDA receptor antagonists
- l-arginine/NO/cGMP pathway inhibitors
- Prospects and future directions
- Conclusion
- Key facts of antidepressants
- Summary points
- Mini-dictionary of terms
- Chapter 18: Translocator protein (18 kDa TSPO) binding in depression
- Abstract
- Introduction: The inflammatory theory of depression
- Postmortem studies and central markers of inflammation
- The translocator protein: A putative marker of neuroinflammation
- In vivo imaging of neuroinflammation in MDD: Initial findings, controversies, and clinical implications
- TSPO binding and cognitive functions in depression
- TSPO binding and response to psychotherapy
- Limitations and future directions
- Key facts of translocator protein (TSPO 18 kDa)
- Key facts of inflammation and depression
- Summary points
- Mini-dictionary of terms
- Chapter 19: Axonal transport proteins: What they are and how they relate to depressive behaviors
- Abstract
- What is axonal transport?
- Axonal transport and brain function
- Axonal transport proteins and neuroinflammation
- Axonal transport proteins and neurodegeneration
- Axonal transport proteins and depressive-like behavior
- Conclusion
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 20: Molecular features of adenylyl cyclase isoforms and cAMP signaling: A link between adenylyl cyclase 7 and depression
- Abstract
- Acknowledgments
- Introduction
- Overview of adenylyl cyclases
- cAMP signaling and depression
- Adenylyl cyclase 7
- Adenylyl cyclase 7 and depression
- Conclusions
- Key facts of cAMP signaling
- Key facts of AC7
- Summary points
- Mini-dictionary of terms
- Chapter 21: Neurobiology of depression: The role of glycogen synthase kinase 3
- Abstract
- Introduction
- Posttranslational mechanisms regulating GSK3 activity
- GSK3β in mood disorders and depression
- GSK3 and experimental models of depression-like behaviors
- Role of GSK3 in regulating intrinsic excitability
- GSK3 and voltage-gated sodium (Nav) channels
- GSK3 and accessory proteins of the voltage-gated sodium (Nav) channel complex
- GSK3 phosphorylation of the voltage-gated sodium (Nav) channel in experimental models of vulnerability to depression-like behavior
- GSK3 and voltage-gated potassium (Kv) channels
- Functional implications of GSK-3-dependent Kv4.2 phosphorylation
- GSK3 and Kv channels in experimental models of depression-like behaviors
- Conclusions
- Key facts of GSK3
- Summary points
- Mini-dictionary of terms
- Chapter 22: Sortilin/neurotensin receptor-3 and its derived peptides in depression
- Abstract
- Introduction
- How TREK-1 became a target in depression
- How sortilin was shown to be involved in depression
- Spadin and spadin analogs are selective fast-acting antidepressants
- Posttranslational products of NTSR3/sortilin as biomarkers
- The role of spadin as a link between obesity/diabetes and depression
- Conclusions
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 23: Implication of Wnt/beta-catenin signaling and its components in depression and neuropsychiatric disorders
- Abstract
- Introduction
- The canonical Wnt signaling pathway
- Noncanonical Wnt signaling pathway
- Wnt/Ca+ 2 pathway
- Wnt/PCP pathway
- Wnt/β-catenin signaling components in depression
- Disheveled
- GSK-3β
- Wnts
- Frizzled
- Crosstalk between neurogenesis and Wnt signaling in depression and psychiatric disorders
- Antidepressants utilize Wnt signaling and its components for the action
- Concluding remarks
- Key facts of Wnt signaling and depression
- Summary points
- Mini-dictionary of terms
- Chapter 24: The prefrontal cortex in depression: Use of proteomics
- Abstract
- Introduction
- OMICS allowed a new insight into neuronal phenotype
- The basics of proteomic studies
- Proteomic studies in depression research
- Proteome changes in depression
- Limitations and perspectives
- Key facts of proteomics
- Summary points
- Mini-dictionary of terms
- Part III: Neurological and imaging features
- Chapter 25: How brain single photon emission computed topography imaging informs the diagnosis and treatment of mood disorders
- Abstract
- Introduction
- Imaging does not match the DSM, but can enhance it
- Brain SPECT imaging
- SPECT mood disorder literature
- Hypofrontality
- Hyperfrontality
- Overall decreased perfusion
- Brain trauma
- Cognitive disorders vs depression
- How SPECT changes clinical practice and may improve outcomes
- SPECT, mood disorders, and treatment response
- Key facts
- Key points
- Summary
- Mini-dictionary of terms
- Chapter 26: Resting-state functional magnetic resonance imaging (rsfMRI) in bipolar and unipolar depression
- Abstract
- Introduction
- A framework for synthesizing rsfMRI results: Distributed functional networks
- Resting-state functional connectivity in unipolar depression
- Resting-state functional connectivity in bipolar depression
- Functional connectivity differences between unipolar and bipolar depression
- Challenges to interpretation of resting-state studies
- Future directions
- Key facts about unipolar and bipolar depression
- Summary points
- Mini-dictionary of terms
- Chapter 27: Linking amygdala blood oxygenation-level-dependent (BOLD) activity and frontal EEG in depression
- Abstract
- Introduction
- Emotion regulation system
- Emotion regulation in depression
- Frontal EEG asymmetry and depression
- Linking amygdala BOLD activity and frontal EEG
- Amygdala real-time fMRI neurofeedback with simultaneous EEG
- EEG activity during the real-time fMRI neurofeedback procedure
- Frontal EEG asymmetry changes and depression severity
- EEG coherence enhancement and depression severity
- Correlations of amygdala BOLD activity and frontal EEG asymmetry
- Conclusion
- Key facts of amygdala and frontal EEG in depression
- Summary points
- Mini-dictionary of terms
- Chapter 28: The rostromedial tegmental nucleus: Features and links with alcohol and depression
- Abstract
- Background
- RMTg: Characteristics, inputs, and outputs associated with alcohol and depression
- RMTg activity in alcohol consumption and depression
- Role of the RMTg in alcohol withdrawal-induced negative affect
- Conclusion
- Key facts of comorbid alcohol use disorders and depression
- Summary points
- Mini-dictionary of terms
- Chapter 29: Human serotonergic neurons, selective serotonin reuptake inhibitor (SSRI) resistance and major depressive disorder
- Abstract
- Introduction
- IPSC reprogramming
- Generating human serotonergic neurons
- Studying serotonergic neurotransmission in patient serotonergic neurons
- Studying serotonergic neurotransmission in patient cortical neurons
- Limitations in iPSC work
- Key facts of serotonergic neurons
- Key facts of induced pluripotent stem cells (iPSCS)
- Summary points
- Mini-dictionary of terms
- Chapter 30: Role of nesfatin-1 in major depression
- Abstract
- Introduction
- Structure and distribution of NUCB protein family
- Molecular structure of nesfatin-1
- Distribution and effects of nesfatin-1
- Nesfatin-1 and psychiatric disorders
- Nesfatin-1 and depression
- Key facts of nesfatin-1
- Summary points
- Mini dictionary of terms
- Chapter 31: Impact of NGF signaling on neuroplasticity during depression: Insights in neuroplasticity-dependent therapeutic approaches
- Abstract
- Acknowledgments
- Introduction
- Changes in neuroplasticity during the pathophysiology of depression
- NGF and neuroplasticity: The evidence
- Role of NGF in the plasticity of hippocampal and basal forebrain cholinergic neurons
- NGF dysregulation in depression
- Clinical evidence
- Preclinical evidence
- NGF regulation in antidepressants treatment
- New perspectives for refining future treatment approaches: Neuroplasticity-dependent therapeutic approaches
- Concluding remarks
- Key facts of depression
- Summary points
- Mini-dictionary of terms
- Chapter 32: Inherited depression and psychological disorders and mental illness by germ cells and their memory
- Abstract
- Disclosure of potential conflicts of interest
- Introduction
- Psychiatric pathologies
- Depression and degradation of germ cells
- Genetic memory
- Do the same causes produce the same effects in humans?
- Wartime, depression, and germ cells
- Psychological and environmental factors and female–male germ cells-fertility
- Transmission of trauma via germ cells
- Reverse process
- Exercise, nutritional status, seasonal variations, and germ cells
- What is happening inside and beyond the uterus?
- Psychotherapy and sexual behavior
- Cognitive/physical activities and sexual behavior
- Relaxation and music/dance therapy
- Discussion
- Conclusion
- Key facts of human germ cells
- Summary points
- Mini-dictionary of terms
- Part IV: Behaviour and psychopathological effects
- Chapter 33: Cognitive function and neurocognitive deficits in depression
- Abstract
- The “hot” and “cold” cognitive processes in depression
- Cognitive predictors of depression
- Cognitive function associated with a depressive episode
- Cognitive function following depressive episode remission
- Conclusion and future directions
- Key facts of cognitive functioning
- Summary points
- Mini-dictionary of Terms
- Chapter 34: Cognitive and interpersonal contributors to relationship distress and depression: A review of the dyadic partner-schema model
- Abstract
- Acknowledgment
- Introduction
- An overview of the dyadic partner-schema model
- Clinical implications of the dyadic partner-schema model
- Directions for future research
- Conclusion
- Key facts of schemas
- Summary points
- Mini-dictionary of terms
- Chapter 35: Cognitive vulnerability to depression in adolescence
- Abstract
- Introduction
- Developmental antecedents to cognitive vulnerability to depression
- Childhood maltreatment and cognitive vulnerability to depression
- Peer victimization and cognitive vulnerability to depression
- Limitations of the research on early life influences of cognitive vulnerability to depression
- Neurobiological findings for early life adversities
- Neurobiological findings for cognitive vulnerability to depression
- Conclusion and future directions
- Key facts of cognitive vulnerability to depression
- Summary points
- Mini-dictionary of terms
- Chapter 36: Determining the cognitive performance in the first episode of depression
- Abstract
- Introduction
- Cognitive dysfunction in MDD
- A brief history of cognitive dysfunction in MDD
- Impact of cognitive dysfunction in MDD
- Cognitive dysfunction in the first episode of MDD
- Conclusions
- Key facts of cognitive dysfunction in the first episode of MDD
- Summary points
- Mini-dictionary of terms
- Chapter 37: Body image and depression
- Abstract
- Introduction
- Tripartite model of body image
- Reciprocal shaping: Body image is shaped by interaction and body image shapes interaction
- Systems view: The neurological layers of embodiment
- Body image assessment
- Studies of the body image in patients with depression
- Discomfort in sensing the body
- Body memory contents of the depressed patients’ body image
- Body image quality and recovery from depression
- Addressing and accepting body image contents in the treatment of depression
- Dance movement therapy in the treatment of patients with depression
- Key facts—Summary points
- Mini-dictionary terms
- Chapter 38: Sleep, anxiety, and depression
- Abstract
- Introduction
- Fundamentals of sleep
- Sleep architecture
- Available treatments for insomnia
- Anxiety disorders
- Treatments for anxiety disorders
- Mechanisms of sleep, anxiety, and depression
- Conclusion
- Key facts
- Mini-dictionary of terms
- Chapter 39: Depression, anxiety, and quality of life
- Abstract
- Introduction
- Measures of qualify of life
- Depression and quality of life
- Effect of treatment for depression on quality of life
- Anxiety and quality of life
- Effect of treatment for anxiety on quality of life
- Conclusions
- Summary points
- Key facts of depression, anxiety, and quality of life
- Mini-dictionary of terms
- Chapter 40: Reward processing and depression: Current findings and future directions
- Abstract
- Introduction
- Theory linking reward processing and depression
- Reward processing and depression: A review of behavioral studies
- An ERP measure of reward processing
- Reward processing and depression: A review of ERP studies
- fMRI measurement of reward processing
- Reward processing and depression: A review of fMRI studies
- Life stress, reward processing, and depression
- Conclusion and future directions
- Key facts of reward learning
- Summary points
- Mini-dictionary of terms
- Chapter 41: Sexual functioning in depression
- Abstract
- Introduction
- The problem statement: Sexual dysfunction in depressed individuals
- Pathophysiology of sexual dysfunction in depression
- Incidence and pathophysiology of TESD/antidepressant-induced sexual dysfunction
- Impact of sexual dysfunction on depression
- Risk factors for developing sexual dysfunction during antidepressant therapy
- Assessment of sexual functioning in patients with depression
- Management of sexual dysfunctions in depression
- Conclusions
- Summary points
- Key facts
- Part V: Diet, nutrition and botanicals
- Chapter 42: Linking dietary glycemic index and depression
- Abstract
- Introduction
- Carbohydrates and glycemic index
- Glycemic responses and depression
- Observational studies
- Clinical trials
- Possible mechanisms
- Conclusion
- Key facts of carbohydrates
- Summary points
- Mini-dictionary of terms
- Chapter 43: Gut microbiota and depression
- Abstract
- Introduction
- Gut microbiota and brain communication
- The mechanisms of action
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 44: Linking dietary methyl donors, maternal separation, and depression
- Abstract
- Introduction
- Experimental models of depression based on stress in perinatal life
- Methyl donors and depression
- Mutations related to depression in genes of one-carbon metabolism
- Conclusion
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 45: Convolvulus pluricaulis usage and depression
- Abstract
- Introduction
- Pathology
- Current synthetic treatment for depression
- Introduction to herbal medicines
- Scientific classification
- Description
- Pharmacological activities of C. pluricaulis
- Effect of C. pluricaulis extract (CPE) in the mouse forced swim and tail suspension tests
- Effect of C. pluricaulis extract (CPE) behavior induced by chronic unpredictable mild stress in rat
- Effect of C. pluricaulis against H2O2-induced neurotoxicity in SH-SY5Y human neuronal cells
- Effect of scopoletin, phytochemical constituent of C. pluricaulis in tail suspension tests
- Effect of Kaempferol, a phytochemical constituent of C. pluricaulis in TST and FST
- Conclusion
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 46: Antidepressant activity of Crocus sativus L. and its main constituents: A review
- Abstract
- Introduction
- Antidepressant activity of saffron
- Antidepressant activity of saffron constituents and its bioactive fractions
- Bioactive fractions of C. sativus L.
- Conclusion
- Summary points
- Key facts
- Mini-dictionary of terms
- Chapter 47: Mechanisms of action of herbal antidepressants
- Abstract
- Introduction
- Herbal antidepressants
- Conclusion
- Key facts
- Summary points
- Mini-dictionary of terms
- Chapter 48: Antidepressant-like effects and mechanisms of the herbal formula Xiaochaihutang in depression
- Abstract
- Introduction
- Effects of XCHT on depressive animal models
- Antidepressant mechanisms of XCHT
- Conclusion
- Key facts
- Summary points
- Mini-dictionary of terms
- Part VI: Resources
- Chapter 49: Recommended resources on the neuroscience of depression: Genetics, cell biology, neurology, behavior, and diet
- Abstract
- Acknowledgments
- Introduction
- Resources
- Summary points
- Mini-dictionary of terms
- Key facts
- Index for Volume 1
- Index for Volume 2
- Edition: 1
- Published: March 22, 2021
- Imprint: Academic Press
- No. of pages: 1166
- Language: English
- Paperback ISBN: 9780128180099
- eBook ISBN: 9780128180105
CM
Colin R. Martin
LH
Lan-Anh Hunter
VP
Vinood Patel
VP
Victor R Preedy
RR
Rajkumar Rajendram
Dr Rajkumar Rajendram is a clinician scientist with a focus on internal medicine, anaesthesia, intensive care and peri-operative medicine. He graduated with distinctions from Guy’s, King’s and St. Thomas Medical School, King’s College London in 2001. As an undergraduate he was awarded several prizes, merits and distinctions in pre-clinical and clinical subjects.
Dr Rajendram began his post-graduate medical training in general medicine and intensive care in Oxford. He attained membership of the Royal College of Physicians (MRCP) in 2004 and completed specialist training in acute and general medicine in Oxford in 2010. Dr Rajendram subsequently practiced as a Consultant in Acute General Medicine at the John Radcliffe Hospital, Oxford.
Dr Rajendram also trained in anaesthesia and intensive care in London and was awarded a fellowship of the Royal College of Anaesthetists (FRCA) in 2009. He completed advanced training in regional anaesthesia and intensive care. He was awarded a fellowship of the Faculty of Intensive Care Medicine (FFICM) in 2013 and obtained the European diploma of intensive care medicine (EDIC) in 2014. He then moved to the Royal Free London Hospitals as a Consultant in Intensive Care, Anaesthesia and Peri-operative Medicine. He has been a fellow of the Royal College of Physicians of Edinburgh (FRCP Edin) and the Royal College of Physicians of London (FRCP Lond) since 2017 and 2019 respectively. He is currently a Consultant in Internal Medicine at King Abdulaziz Medical City, National Guard Heath Affairs, Riyadh, Saudi Arabia.
Dr Rajendram’s focus on improving outcomes from Coronavirus Disease 2019 (COVID-19) has involved research on point of care ultrasound and phenotypes of COVID-19. Dr Rajendram also recognises that nutritional support is a fundamental aspect of medical care. This is particularly important for patients with COVID-19. As a clinician scientist he has therefore devoted significant time and effort into nutritional science research and education. He is an affiliated member of the Nutritional Sciences Research Division of King’s College London and has published over 400 textbook chapters, review articles, peer-reviewed papers and abstracts.